About John Springer
Form D filings for R3 Vascular from 2020 to 2024 list John Springer as director.
John Springer first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name John Springer in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people John Springer works with at each company, as listed on that company's latest Form D.
R3 Vascular Inc. · Form D, Sep 12, 2024
KR
Kamal Ramzipoor
CTO, Founder
FG
Frederik Groenewegen
Director
MH
Michael Hurley
Director
DN
David Neustaedter
Director
CO
Christopher Owens
President and Chief Executive Officer, director
Amir Abolfathi
Director
NH
Nathan Harrington
Director